Woodcasting Versus Thermoplast Splint in CMC Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFoundation for Orthopaedic Research and Education
About this trial
This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.
Eligibility criteria
Qualifiers
Patients over the age of 18 years old.
Intact Medical Decision Making
Eligible for Surgical Intervention
Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks
Disqualifiers
Pregnant Women
Deemed Unsuitable by Principal Investigator
Trial design
Treatments tested in this trial
- Woodcasting Splint
- Control (Standard treatment)
Treatment groups
26 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov